ROLL, MSLP, RCRC, RCS - DrStockPick.com Stock Report! 25th 2010
Monday, October 25th, 2010
**************************************************************
MusclePharm(R) Corporation (OTCBB:MSLP), formerly Tone in Twenty, is a development-stage company. On February 18, 2010, the Company acquired Muscle Pharm, LLC (Muscle Pharm). As a result of this transaction Muscle Pharm became a wholly owned subsidiary of the Company.
Muscle Pharm manufactures and markets six sports nutrition products: Combat Powder, Assault, Battle Fuel, Bullet Proof, Shred Matrix and Recon. These products consist of amino acids, herb and proteins scientifically tested for the overall health of athletes. It sells its products under the MusclePharm brand. Its MusclePharm brand products target athletes, body builders and health-minded individuals. The Company’s products are available in over 120 countries worldwide, through specialty retailers, such as GNC Canada, The Vitamin Shoppe, BodyBuilding.com, international distributors, and the United States sports nutrition distributor, Europa Sports. The Company’s primary manufacturer is located in Canada.
MSLP today announced that the host and Musclepharm athlete, TJ Lavin, will be wearing Musclepharm apparel throughout all episodes from October thru December, 2010.
The MTV Challenge premiered on October 6th, 2010, and the final episode will air on December 15th, 2010. The re-airs of each episode will take place throughout each week. There will be 10 premier episodes with each episode having up to 15 re-runs.
MSLP, sponsered Jake Shields won his UFC debut, but struggled to get it, pulling off a split decision over Martin Kampmann. Shields seemed to be completely gassed by the middle of the second round and struggled to do much in the final seven or eight minutes.
MSLP ’s award-winning products — Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix — are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.
MusclePharm is presently preparing their application for Recon to be added to the Medicaid formulary, beginning in New York State for people diagnosed with HIV and AIDS as well as nation-wide Veterans Administration therapeutic formularies. In addition, MusclePharm is exploring the distribution of MusclePharm products, such as Recon, to people living with HIV in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR).”
More about MSLP at: www.musclepharm.com
*****************************
RBC Bearings Incorporated (Nasdaq: ROLL), a leading international manufacturer of highly-engineered precision plain, roller and ball bearings for the industrial, defense and aerospace industries, reported results for the first quarter of fiscal year 2011. Net sales for the first quarter of fiscal 2011 were $82.4 million, an increase of 29.3% from $63.7 million in the first quarter of fiscal 2010. The increase in net sales was mainly the result of a 96.5% increase in industrial sales driven by strong orders in construction and mining, semiconductor, military vehicles, and the general industrial markets.
RBC Bearings Incorporated is an international manufacturer and marketer of highly engineered precision bearings and components.
*****************************
RC2 Corporation (NASDAQ:RCRC), released its results for the third quarter and nine months ended September 30, 2010. RC2 reported net income for the third quarter 2010 of $12.4 million, or $0.56 per diluted share, compared with $13.6 million, or $0.66 per diluted share, for the third quarter 2009. Excluding the impact of retailer product returns, inventory charges and costs related to infant sleep positioners and acquisition-related costs, net income was $13.9 million, or $0.63 per diluted share, for the third quarter 2010. RC2 reported net income for the nine months ended September 30, 2010, of $19.6 million, or $0.89 per diluted share, compared with $18.7 million, or $1.01 per diluted share, for the nine months ended September 30, 2009. Excluding the impact of retailer product returns, inventory charges and costs related to infant sleep positioners and acquisition-related costs, net income was $21.1 million, or $0.96 per diluted share, for the nine months ended September 30, 2010.
RC2 Corporation is a leading designer, producer and marketer of a broad range of innovative, high-quality products for mothers, infants, and toddlers, as well as toys and collectible products sold to preschoolers, youths and adults.
*****************************
PIMCO Strategic Global Government Fund, Inc. (NYSE:RCS), a non-diversified, closed-end management investment company which as a primary objective seeks to generate, over time, a level of income higher than that generated by high-quality, intermediate-term U.S. debt securities and as a secondary objective, seeks to maintain volatility in the net asset value of the shares of the Fund comparable to that of high-quality, intermediate-term U.S. debt securities, revealed its results for the fiscal quarter and six months ended July 31, 2010.
PIMCO Strategic Global Government Fund, Inc. operates as a nondiversified and closed-end management investment company.
**************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

















